Introduction: The use of complementary and alternative medicine (CAM) in the Irish pediatric cancer setting has not previously been established.
Methods:
To investigate the prevalence and predictors of CAM use in this group of patients, an anonymous cross-sectional survey was offered to all carers of patients either on or off treatment for malignancy at a single pediatric cancer center over an 8-week period.
Results: Of a total of 220 questionnaires distributed, 98 (43%) were returned. Six were excluded because of inadequate data. A total of 58% of children were male and the mean age was 9 years. The most common cancer diagnosis was leukemia (45%). Fifty-two respondents (57%) said their child had used or was using CAM, and 55% of whom had started since their cancer diagnosis. The most common types of CAM used were vitamins and minerals (18%), reflexology (11%), dietary supplements (11%), faith healers (9%), and energy therapies (9%). The most common reason for CAM use was to improve physical well-being (31%). A total of 65% of CAM users had not told their doctor that they were doing so. Of the 52 CAM users, 30 (58%) were using oral CAM medication. A total of 86% of CAM users reported benefit from the treatment, and no respondent reported side effects. There was no significant relationship between sex, tumor type, age, income, previous treatment, and CAM use. Where parents had a higher level of education, children were more likely to use CAM (P = 0.035.) There was a statistically significant relationship between respondents rating of conventional therapy and CAM use (P = 0.007). Interestingly, parents who were satisfied with conventional therapy were more likely to use CAM.
Conclusion:
The high prevalence of CAM use demonstrated in this study and particularly the high use of CAM medication therapies underlines the importance of physicians asking routinely about CAM use in this population.
Key Words: complementary and alternative medicine, hematology, oncology, cancer, pediatric (J Pediatr Hematol Oncol 2013;35:537-542) C omplementary and alternative medicine (CAM) is a group of diverse medical health care systems, practices, and products that are not presently considered to be part of conventional medicine. 1 It has been found that the use of CAM among pediatric patients in a variety of circumstances is increasing 2 and this has recently been borne out in an Irish population. 3 The World Health Organization categorizes CAM as nonmedication and medication therapies, 4 the latter of which is of particular interest to hematologists and oncologists as these therapies may potentially interact with prescribed cytotoxic medicines. The prevalence of CAM use by pediatric hematology/oncology patients has been found to range between 6% and 91%, 5 however, to date its use in the Irish pediatric hematology/oncology cancer population has not been examined. Our aim was to establish the prevalence of its use in this group and the factors that influence its use or lack thereof.
METHODS

Ethical Considerations
Ethical approval for the study was granted by the Ethics Committee at Our Lady's Children's Hospital, Crumlin before distribution of the questionnaires.
Methods
The study design was a cross-sectional survey, carried out among patients attending the National Paediatric Haematology and Oncology Centre at Our Lady's Children's Hospital, Dublin. The questionnaire design was based on multiple previously validated questionnaires assessing CAM use. [5] [6] [7] In particular, we were guided by the findings and recommendations by Bishop et al 5 who analyzed 28 previous CAM surveys and advised on the most important questions to include in order to standardize survey methods to produce comparable data.
The questionnaire was offered to all carers of patients attending for treatment of malignancy in the day ward or inpatient unit or patients attending for follow-up in the outpatient department over an 8-week period, from May to June 2011.
The questionnaires were anonymous. They included questions pertaining to their child's use or nonuse of CAM, patient demographics such as sex, age, ethnicity, marital status, education level, income of parent/guardian, primary site of cancer, previous treatments for cancer, child's current prescribed medicines, and parent's level of satisfaction with cancer treatment to date. The questionnaire was in the form of check boxes or multiple-choice items. The demographics of those who did not complete the questionnaire were not obtained.
If the child had used CAM, they were asked about the frequency of use, whether use predated cancer diagnosis, reasons for use, benefit or side effects from use, whether their doctor was informed, and where they learned about these therapies. An open-ended commentary box was included for any additional comments. Parents whose children did not use CAM were asked to choose from a number of reasons provided for not doing so and a free text box for commentary.
A total of 220 questionnaires were distributed by the primary investigators to parents/guardians of children who were inpatients and by clerical and medical staff as they registered in the day ward or outpatient clinics. An explanatory cover letter, assuring parents/guardians of anonymity accompanied each questionnaire. A telephone number for the palliative care liaison nurse was provided, in case any queries arose. Questionnaires were returned to a sealed box.
Analysis
Data were entered into SPSS for analysis. Descriptive analyses and frequencies were used to describe and rank the use of CAM. w 2 tests were used to assess correlations between demographics and CAM use. Significance was accepted at a level of P < 0.05.
RESULTS
Of a total of 220 questionnaires distributed, 98 (43%) were returned. Of these, 6 were excluded because of inadequate data leaving 92 completed questionnaires for analysis.
Demographics
There were more male children (58%) than female (42%) in the sample (Table 1) . Ninety-nine percent of respondents' children were white and the mean age was 9 years, with a range of <1 year to 18 years. A parent completed the form in all but one case, where a 13-year-old child completed the form. This was felt acceptable by the investigators. Most (84%) parents were married. The majority (62%) of parents had education to a level greater than Leaving Certificate (Irish equivalent of A-levels). More than a third (37%) of households had an annual income of >h40,000 ( Table 1) .
The most common malignancy was leukemia (45%) followed by brain tumors (13%), sarcoma/osteosarcoma (12%), neuroblastoma (8%), lymphoma (7%), tumors of the kidney (6%), and other cancers (9%) ( Table 1) .
Ninety-two percent of the respondents had or were having chemotherapy, 42% surgery, 24% radiotherapy, and 5% antibody treatment. Fifty-six respondents listed the medications their child was currently taking, the most common of which were antibiotics (21%), cytotoxic medicines (21%), steroids (18%), and analgesics (10%).
CAM Use
Of the 92 respondents, 52 (57%) parents said their child had used or were using CAM. Fifty-five percent of CAM users had only done so since their cancer diagnosis.
The most common types of CAM used were vitamins and minerals (18%), reflexology (11%), dietary supplements (11%), faith healers (9%), and energy therapies for example, reiki (9%) ( Table 2 ). Of the 52 CAM users, 30 (58%) were using oral CAM medication therapies (vitamins and minerals, dietary supplements other than those prescribed by a doctor or dietician, herbal medicines, homeopathy, or herbal teas).
Thirty-two percent of CAM users only did so less than once per month but 30% used CAM on a daily basis.
Eighty-six percent of CAM users reported benefit from the treatment and no respondent reported side effects.
Sources of information about CAM were mostly personal knowledge (34%) and from family and friends (34%).
A nurse had provided information about CAM in 9% of cases, a doctor in 8%, and only 6% of CAM users had found information pertaining to CAM on the Internet.
Factors Influencing CAM Use
Indications for incorporation of CAM therapy are documented in Figure 1 . The most common reason cited for CAM use was "to improve physical well-being" (31%). Only 6% used CAM "to directly fight the disease/decrease the tumor" and only 1 patient said they used CAM because their doctor had advised it.
Although 60% of boys compared with 50% of girls used CAM, this was not found to be statistically significant ( Table 1) . Five of the 7 children with neuroblastoma (71%) used CAM, making them the highest percentage per tumor type but again, this was not to a statistically significant level ( Table 1 ). Children of parents who had received education beyond leaving certificate level were statistically more likely to use CAM than those with leaving certificate level education or less (P = 0.03) ( Table 1) . The relationship between household income and CAM use neared significance (P = 0.08). There was no statistically significant relationship between CAM use and tumor type, child's age, parent's marital status, or conventional treatment children had received (Table 1) .
There was a statistically significant relationship between respondents rating of conventional therapy and CAM use (P = 0.007). Interestingly, parents who were satisfied with conventional therapy were more likely to use CAM. There was a very high overall satisfaction level with conventional therapy (Fig. 2) .
The most common reason for not using CAM was being "happy with conventional treatment." Twenty-two percent of respondents felt that there was a lack of information about CAM treatments (Fig. 3) .
Disclosure of CAM Use to Doctors
The majority of CAM users (65%) had not told their doctor that they were doing so. Of those using oral CAMs, 56% had not informed their doctor. 
DISCUSSION
The use of CAM in both adults and children with cancer has been found to be prevalent and increasing worldwide. 1, 2, 5, [8] [9] [10] Studies examining the rate of use vary hugely. One systematic review of CAM use in 13 countries found its use to range from 7% to 64%. 2 Another ranged from 6% to 91%. 5 These wide ranges of CAM prevalence internationally make it particularly important for local review of CAM practices, particularly in the cancer setting where patients are especially at risk of both side effects and interactions. Previous Irish studies in adult cancer patients have found the prevalence of CAM use to be 21.7% in a head and neck cancer cohort 6 and more recently 29.1% in a mixed oncology sample. 11 This is the first study to date to specifically examine CAM use in the Irish pediatric hematology/oncology cancer population where we found the rate of CAM use to be much higher than that of Irish adults at 57%.
Low et al 3 examined the use of CAM in the general pediatric setting in Ireland and found an identical prevalence of 57%. Our findings regarding disclosure of CAM use to medical staff is also very consistent with other studies. 5, [10] [11] [12] [13] The majority (65%) of parents had not informed their doctor that their child was using CAM, which is also consistent with findings in the general Irish pediatric setting where 54% had not informed their doctor. 3 An interesting question that we did not address was whether parents had been specifically asked about CAM use. Roth et al 14 examined this topic previously in the United States in a survey of 101 pediatric oncologists and found that 7% never asked, 43% occasionally asked, 13% asked half of the time, 26% asked most of the time, and 11% always asked about CAM use. Very practical reasons that are likely to resonate with most physicians such as lack of time and lack of knowledge were cited for not always asking. In a recent Irish study, health care professionals' knowledge of CAM was assessed by asking 5 questions based on level 1a evidence. The majority were undecided on all 5 questions highlighting the lack of knowledge regarding these treatments and their potential uses and benefits. 11 It is possible that physicians may inquire about CAM use on initial assessment as a routine but not routinely on every other visit. Since the majority of CAM users in this study had begun to use CAM since diagnosis, this approach is likely to fail in getting an overall perspective on CAM therapies.
A part time complementary therapist has recently been appointed to the pediatric cancer center where this study was conducted. She provides therapies such as aromatherapy, reflexology, and relaxation techniques. By and large, treating physicians tend to be more comfortable with these nonmedication treatments than with oral therapies. Our study found that a high proportion of CAM therapies included agents that have the potential to interact with prescribed cancer treatments.
CAM use is potentially a very lucrative industry. The National Centre of Complementary Medicine have estimated that the United States spend >$34 billion per year on CAM therapies. 13 In Ireland, while an increased use and availability of CAM retail outlets and practices can be seen, this sector is, as yet, largely unregulated.
In response to this, the Irish government had set up a national working group on the regulation on complementary therapists in 2003 and published their report in 2006. The reports highlighted that "there is, at present, no one source of independent, external assessment, validation, and accreditation which would provide for monitoring of educational programmes and of providers, tutors, and examiners." 15 This is an obvious barrier to the acceptance of CAM by medical practitioners. It is a very real and reasonable concern for pediatricians as it is impossible for them to advocate or approve a treatment for which there is little or no regulation or governance.
However, the body of evidence on CAM is growing. While research in Ireland is lacking, other countries, such as the United States have established funded research bodies-the National Centre for Complementary and Alternative Medicine. These bodies award research grants and establish centers of learning as well as coordinating trials, information sharing, and improving the quality of research being conducted. In the recent years, this has produced a rise in the quality and quantity of research and has led to a wider evidence base for the efficacy of a number of CAM approaches and treatments. 15 As a result, evidence-based data at 1a level has been produced for a number of CAM treatments such as the use of acupuncture for chemotherapy induces vomiting, 16 the use of Chinese herbs for chemotherapy side effects in colorectal cancer patients 17 and the use of ginger for nausea and vomiting. 18 Instinctively, one might assume that use of CAM reflects dissatisfaction with conventional treatment and an expression of frustration at treatments and the often difficult path it entails for both children and parents. However, this study shows very high levels of satisfaction with parents' experience of conventional medicine in a group where there is a high level of CAM use. It could be argued that in carrying out this study in a treatment center, all patients who have fully rejected conventional treatment are excluded and indeed this is the case. However, it remains that the majority of patients on conventional treatment use CAM, as the majority of CAM users are on conventional treatments. It would be a safer practice for all parties concerned if physicians adopted a more robust system for both enquiring about CAM use and also if physicians were better informed about CAM and both its potential for advantage and interaction. We have enough evidence to conclude that CAM and conventional treatments are not mutually exclusive and CAM use does not imply dissatisfaction with conventional medicine.
This theory that CAM is most often used as an adjuvant to conventional treatments is strengthened by the reasons cited for its use. In this study only 6% of parents stated that they were using CAM "to directly fight the cancer." The most common reasons for the parents in this study in utilizing CAM treatment were to "improve physical well-being" and "to improve emotional well-being, provide hope, and increase optimism." Having a child with a cancer diagnosis is a hugely stressful situation for parents to find themselves in. There is bound to be a feeling of loss of control when catapulted into such an unfamiliar environment. Providing children with CAM provides parents with a degree of input into their child's care and a certain sense of control and autonomy.
Parents with a higher level of education were significantly more likely to use CAM in this study. While other studies would concur with this finding, 6, 11, 13, 19, 20 a systematic review by Bishop et al 5 found no association between CAM use and the sociodemographic characteristics. Here we found no correlation with income but a high overall prevalence of CAM use in a group with a higher than average household income with 37% of the sample household earning >h40,000/year. The reason for such high incomes in our sample is unclear. The study was carried out in a public hospital as no private pediatric practice exists in Ireland. Only 7% of non-CAM users cited difficulties with payment as the reason for not using CAM indicating that cost is not a deterrent to CAM use in this sample.
CONCLUSIONS
This study reveals that the use of CAM is widespread among pediatric cancer patients in Ireland. There is an urgent need for regulation of this area of medicine. Rather than ignoring the issue, physicians must begin to routinely inquire regarding CAM use and its potential interactions on a regular basis. The government needs to regulate CAM in Ireland so that the quality and accountability can be assured as well as increasing medical knowledge of CAM and promoting robust research in this area. The outcome of this would surely be wider acceptance of CAM and most importantly safety and the highest quality of care for children with cancer.
